Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Second Opinion Expert Announces Release of Online COVID-19 Risk Assessment

Free comprehensive assessment tool now available on Internet.


News provided by

SecondOpinionExpert, Inc.

Apr 14, 2020, 11:00 ET

Share this article

Share toX

Share this article

Share toX

COVID-19 Risk Assessment
COVID-19 Risk Assessment

DANA POINT, Calif., April 14, 2020 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading health care technology company, announced today that it is providing free online access to a comprehensive assessment questionnaire for anyone seeking an evaluation of their current level of risk related to the COVID-19 virus. The evidence-based tool was developed by medical experts based on the latest global data on the virus. It will help people make better personal health care decisions about their COVID-19 risk and will aid in efforts to combat the spread of the disease.

The online questionnaire helps determine an individual's risk from possible exposure to COVID-19 by taking into account all the factors, stages and variances in symptoms to provide a perspective on their unique current status. As an evidence-based assessment, it focuses on the user's history and symptoms and is a safe and effective means to help make prudent health care decisions in regards to the COVID-19 pandemic. The tool provides users with recommended possible next steps that they can explore as needed with a physician or other medical provider.

Our hope that this fast, free and comprehensive risk assessment tool will help save lives. Our plan is to continue to work alongside public health organizations to provide effective solutions that benefit society.

Post this

Since the assessment is performed online, users do not have to leave home, thus avoiding the risk of potential exposure involved with visiting a medical facility or lab. Results are displayed immediately at the conclusion of the assessment, providing the ability to review and download a full report. The report, along with a comprehensive list of current symptoms, can then be shared digitally with a physician in consultation on appropriate next steps. All personal information is completely secure and confidential utilizing SOE's patented HIPAA compliant technology platform which adheres to the highest standards of data security. Data and results are private unless users specifically authorize access to their physician or other health care providers.

The evidence based online digital assessment is not a substitute for the biological test, but complementary to the biological test. Results are not binary (yes or no) like a biological test, but are a four-level risk assessment for infection: 1) Remote, 2) Possible, 3) Probable, or 4) Certain. One advantage of this assessment is that users only need to seek medical help in the case of "Certain Infection" or "Probable infection." Moreover, the assessment can be taken any number of times as the situation changes.

"I have reviewed the questions and I have contributed to the development of this innovative tool," said Dr. Venkatraman Sadanand, Pediatric Neurosurgeon and member of the SOE expert physician panel. "Some of my patients have taken this assessment, and the results are very accurate. I would recommend for anyone to take it, and based on the results discuss it with their personal physician."

The assessment can be accessed at https://www.secondopinionexpert.com/covid19.

"We are pleased to leverage the power of our patented technology platform and medical expertise to help in the global fight against the spread of COVID-19," said Steve Krause, President, SecondOpinionExpert, Inc. "Our hope that this fast, free and comprehensive risk assessment tool will help save lives. Our plan is to continue to work alongside public health organizations to provide effective solutions that benefit society."

About SecondOpinionExpert
SecondOpinionExpert, Inc. (SOE) helps people make the best possible health care decisions through effective use of medical second opinions. Our patented technology makes it fast, easy and affordable to gain the perspective of a world-class, board-certified medical specialist on whatever medical decision is needed.

SecondOpinionExpert's online technology increases the quality and efficiency of health care delivery, improves health care access, and empowers patients to make better informed medical decisions. The HIPAA-compliant platform leverages recent advancements in information technology and electronic medical record systems enabling the company to provide fast, reliable and secure online medical opinions. The system provides patients greater peace of mind in knowing that they have a medical expert's perspective for their medical decisions.

SOE offers exclusive, one-on-one, professional diagnostic evaluations to patients across the United States and around the globe. We also offer attractive plans for utilizing second opinions as an employee benefit, which helps hold down rising health care premiums. Our skilled panel is comprised of hundreds of physician specialists with exemplary academic credentials as well as significant patient care experience in all major diagnostic specialties and subspecialties. Utilizing our patented processing technology and databases, our physicians can more efficiently and effectively review a patient's prior tests and symptoms when writing a second opinion report. Thereafter, the patient may also request a secure teleconsult with the physician, to address any remaining questions. Our technology is available for use here in the US and worldwide. Our patent is also available to be licensed, and the platform can be customized for government, institutional or enterprise use.

Additional information can be found at http://www.secondopinionexpert.com

SOURCE SecondOpinionExpert, Inc.

Related Links

http://www.secondopinionexpert.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.